LV-MAX Lentiviral Production System Promotion

From now through June 30, 2018, save 50% off the LV-MAX Lentiviral Production System*

The Gibco LV-MAX Lentiviral Production System is the first optimized system that provides a scalable and high-yield lentiviral vector production platform.

It is based on a suspension, high-density culture of HEK 293-derived Viral Production Cells adapted to a special chemically defined, serum-free and protein-free LV-MAX Production Medium.

The LV-MAX Lentiviral Production System provides:

  • High titer – greater than 1 x 108 TU/mL (unconcentrated LVVs-GFP)
  • Scalable suspension system – from 96 deep-well plate to 2-L bioreactor
  • Serum-free – eliminating animal-origin components and associated risks
  • Easy, robust culture and transfection protocols – fits into current transient production workflows
Learn more ›